CT-019780

N/A

Report date: 2025/01/26 17:08:10
NME

Base Information

Drug NameCT-019780
Drug Alias NameCT-0093 seriesCT-019780
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane-associated progesterone receptor component 1 antagonistsBeta amyloid A4 protein inhibitors
TargetsMembrane-associated progesterone receptor component 1Beta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognition Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCognition Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A